List of Bluebird Bio patents

Patents where

Current Assignee

Name

Bluebird Bio

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11326183 VCN enhancer compositions and methods of using the same	Patent 11326183 was granted and assigned to Bluebird Bio on May, 2022 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	11326183	May 10, 2022
‌ US Patent 10479975 Methods of making T cell compositions	Patent 10479975 was granted and assigned to Bluebird Bio on November, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10479975	November 19, 2019
‌ US Patent 10457731 Multipartite signaling proteins and uses thereof	Patent 10457731 was granted and assigned to Bluebird Bio on October, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10457731	October 29, 2019
‌ US Patent 7901671 Therapeutic retroviral vectors for gene therapy	Patent 7901671 was granted and assigned to Bluebird Bio on March, 2011 by the United States Patent and Trademark Office.		Bluebird Bio	United States Patent and Trademark Office	7901671	March 8, 2011
‌ US Patent 10383929 BCMA chimeric antigen receptors	Patent 10383929 was granted and assigned to Bluebird Bio on August, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10383929	August 20, 2019
‌ US Patent 11020466 BCMA chimeric antigen receptors	Patent 11020466 was granted and assigned to Bluebird Bio on June, 2021 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	11020466	June 1, 2021
‌ US Patent 10927367 CBLB endonuclease variants, compositions, and methods of use	Patent 10927367 was granted and assigned to Bluebird Bio on February, 2021 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10927367	February 23, 2021
‌ US Patent 11535681 Sickled beta globin antibodies		Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	11535681	December 27, 2022
‌ US Patent 10196444 Multipartite signaling proteins and uses thereof	Patent 10196444 was granted and assigned to Bluebird Bio on February, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10196444	February 5, 2019
‌ US Patent 10428142 Multipartite signaling proteins and uses thereof	Patent 10428142 was granted and assigned to Bluebird Bio on October, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10428142	October 1, 2019
‌ US Patent 10774343 MND promoter chimeric antigen receptors	Patent 10774343 was granted and assigned to Bluebird Bio on September, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10774343	September 15, 2020
‌ US Patent 10646558 BCMA chimeric antigen receptors	Patent 10646558 was granted and assigned to Bluebird Bio on May, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10646558	May 12, 2020
‌ US Patent 10624960 BCMA chimeric antigen receptors	Patent 10624960 was granted and assigned to Bluebird Bio on April, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10624960	April 21, 2020
‌ US Patent 10639359 BCMA chimeric antigen receptors	Patent 10639359 was granted and assigned to Bluebird Bio on May, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10639359	May 5, 2020
‌ US Patent 10639358 BCMA chimeric antigen receptors	Patent 10639358 was granted and assigned to Bluebird Bio on May, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10639358	May 5, 2020
‌ US Patent 10793843 CBLB endonuclease variants, compositions, and methods of use	Patent 10793843 was granted and assigned to Bluebird Bio on October, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10793843	October 6, 2020
‌ US Patent 9061031 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy	Patent 9061031 was granted and assigned to Bluebird Bio on June, 2015 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	9061031	June 23, 2015
‌ US Patent 9988644 Compounds for improved viral transduction	Patent 9988644 was granted and assigned to Bluebird Bio on June, 2018 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	9988644	June 5, 2018
‌ US Patent 10501759 Compounds for improved viral transduction	Patent 10501759 was granted and assigned to Bluebird Bio on December, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10501759	December 10, 2019
‌ US Patent 10907177 Compounds for improved viral transduction	Patent 10907177 was granted and assigned to Bluebird Bio on February, 2021 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10907177	February 2, 2021
‌ US Patent 9783822 Gene therapy methods	Patent 9783822 was granted and assigned to Bluebird Bio on October, 2017 by the United States Patent and Trademark Office.		Bluebird Bio	United States Patent and Trademark Office	9783822	October 10, 2017
‌ US Patent 10576133 BCMA chimeric antigen receptors	Patent 10576133 was granted and assigned to Bluebird Bio on March, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10576133	March 3, 2020
‌ US Patent 10576134 BCMA chimeric antigen receptors	Patent 10576134 was granted and assigned to Bluebird Bio on March, 2020 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10576134	March 3, 2020
‌ US Patent 8034620 Lentiviral packaging cells and uses therefor	Patent 8034620 was granted and assigned to Bluebird Bio on October, 2011 by the United States Patent and Trademark Office.		Bluebird Bio	United States Patent and Trademark Office	8034620	October 11, 2011
‌ US Patent 10280435 Gene therapy methods	Patent 10280435 was granted and assigned to Bluebird Bio on May, 2019 by the United States Patent and Trademark Office.	Bluebird Bio	Bluebird Bio	United States Patent and Trademark Office	10280435	May 7, 2019

Results per page:

28 results

0 selected

28 results

0 selected